Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

More protein farnesyltransferase inhibitors from Warner-Lambert

May 31, 1996

Research of a recombinant fusion protein in human breast cancer disclosed

May 31, 1996

RPR-112378: A new inhibitor of tubulin polymerization

May 31, 1996

Encouraging results reported in paclitaxel and cisplatin-based therapy combination

May 31, 1996

Topotecan hydrochloride exhibits positive results in recurrent ovarian cancer patients

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

Vinorelbine tartrate and cisplatin cocktail more effective than cisplatin alone

May 31, 1996

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Anthracycline antitumor agent FCE-23762 metabolites synthesized

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...